000 02277nam a2200337 a 4500
001 000542242
005 20240105150117.0
008 091103s2008 nyu rb 001 0 eng d
010 _a2007029727
020 _a9780826129345 (alk. paper)
020 _a082612934X (alk. paper)
035 _a350648
040 _aDNLM/DLC
_bspa
_cNLM
_dUIASF
050 4 _aRC 483
_bB72.2008
100 1 _aBreggin, Peter Roger,
_d1936-
245 1 0 _aBrain-disabling treatments in psychiatry :
_bdrugs, electroshock, and the psychopharmaceutical complex /
_cPeter R. Breggin.
250 _a2nd ed.
260 _aNew York :
_bSpringer Pub.,
_c2008.
300 _axxx, 546 p. ;
_c24 cm.
504 _aIncluye referencias bibliográficas (p. 463-526) e índice.
505 0 _aThe brain-disabling, spellbinding effects of psychiatric drugs -- Deactivation syndrome (chemical lobotomy) caused by neuroleptics -- neuroleptic-induced anguish, including agitation, despair, and depression -- Severe and potentially irreversible neurological syndromes (tardive dyskinesia and neuroleptic malignant syndrome) caused by neuroleptics -- Neuroleptic-induced neurotoxicity, brain damage, persistent cognitive deficits, dementia, and psychosis -- Recent developments in antidepressant label changes -- Antidepressant-induced mental, behavioral, and cerebral abnormalities -- Lithium and other drugs for bipolar disorder -- Electroconvulsive therapy (ECT) for depression -- From attention-deficit/hyperactivity disorder (ADHD) to bipolar disorder : diagnosing America's children -- Stimulant-induced brain damage, brain dysfunction, and psychiatric adverse reactions -- Antianxiety drugs, including behavioral abnormalities caused by Xanax and Halcion -- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH) : drug company advocates -- Drug company deceptions -- How to more safely stop taking psychiatric drugs -- Failed promises, last resorts, and psychotherapy.
650 0 _aPsychotropic drugs
_xSide effects
650 4 _aDrogas psicotrópicas
_xEfectos secundarios
650 0 _aBrain
_xEffect of drugs on.
650 4 _aCerebro -
_xEfectos de las drogas
905 _a01
942 1 _cNEWBFXC1
999 _c511057
_d511057
980 _851
_gRonald RUIZ